Adverse events in platelet apheresis donors: A multivariate analysis in a hospital-based program

scientific article

Adverse events in platelet apheresis donors: A multivariate analysis in a hospital-based program is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1046/J.1423-0410.1999.7710024.X
P698PubMed publication ID10474087

P2093author name stringDespotis GJ
Goodnough LT
Spitznagel E
Dynis M
Baorto D
P2860cites workFrequency of immediate adverse effects associated with apheresis donationQ33175808
Complications of plasma exchangeQ38517393
Biomaterials for blood-contacting applicationsQ40647756
Detection of plasmapheresis-induced platelet activation using monoclonal antibodiesQ46876930
Differential induction of P-selectin expression on platelets by two cell separators during plateletpheresis and the effect of gender on the release of soluble P-selectin.Q50905712
P433issue1
P921main subjectmultivariate statisticsQ1952580
P304page(s)24-32
P577publication date1999-01-01
P1433published inVox SanguinisQ15708866
P1476titleAdverse events in platelet apheresis donors: A multivariate analysis in a hospital-based program
P478volume77

Reverse relations

cites work (P2860)
Q37542963A Retrospective Analysis of Apheresis Donor Deferral and Adverse Reactions at a Tertiary Care Centre in India
Q53508615Adverse Events During Apheresis Procedures: Audit at a Tertiary Hospital.
Q36732672Adverse events associated with apheresis procedures: Incidence and relative frequency
Q33157104Adverse reactions during voluntary donation of blood and/or blood components. A statistical-epidemiological study
Q33157218Adverse reactions in blood and apheresis donors: experience from two Italian transfusion centres
Q80521847Arteriovenous fistula formation in a volunteer allogeneic peripheral blood progenitor cell donor
Q30252024Citrate anticoagulation: Are blood donors donating bone?
Q34790959Comparison of Plateletpheresis on the Fenwal Amicus and Fresenius Com.Tec Cell Separators.
Q37589285Consensus and controversies in platelet transfusion
Q45121544Discontinuous automated calcium supplementation during thrombocytapheresis with the MCS+ version C. Absence of severe complication due to calcium deprivation in 4308 procedures
Q33805801Donor Safety in Haemapheresis: Development of an Internet-Based Registry for Comprehensive Assessment of Adverse Events from Healthy Donors.
Q30971646Donor vigilance data of a blood transfusion service: A multicenter analysis
Q46426136Effect of thrombocytapheresis on blood rheology in healthy donors: role of nitric oxide
Q85962044Effects of plateletpheresis on blood coagulation parameters in healthy donors at National Blood Centre, Kuala Lumpur, Malaysia
Q33163008Frequency of adverse events in plateletpheresis donors in regional transfusion centre in North India.
Q92759964Haemostatic parameters, platelet activation markers, and platelet indices among regular plateletpheresis donors
Q33152691Incidents of blood donation
Q33361167Optimizing platelet transfusion therapy
Q73775002Platelet transfusion therapy
Q33148196QTc prolongation in apheresis platelet donors
Q33164521Risk factors associated with the occurrence of adverse events in plateletpheresis donation
Q34762323Risk factors for acute, moderate to severe donor reactions associated with multicomponent apheresis collections
Q33159415Serious adverse effects of blood collection
Q33690874Single-donor platelet apheresis: observational comparison of the new Haemonetics Universal Platelet protocol with the previous Concentrated Single Donor Platelet protocol
Q50515460Switching iron-deficient whole blood donors to plateletpheresis.
Q81548338The effects of plateletpheresis on donor platelet function and coagulation
Q53544180The effects of warming methods on temperature, cardiac function and cytokines in plateletpheresis donors.
Q38371628The role of thrombocytapheresis in the contemporary management of hyperthrombocytosis in myeloproliferative neoplasms: A case-based review.
Q62090516Transfusión de plaquetas, ¿concentrados procedentes de un único o de múltiples donantes?
Q36458599Unique donor-suitability issues
Q48283895Vasovagal reactions in blood donors: risks, prevention and management
Q36287344What's happening: an overview of potential adverse reactions associated with apheresis technology

Search more.